BELLEVUE, WA, March 12 /CNW/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX:ONY),
a biotechnology company specializing in the development of innovative
therapeutic products for the treatment of cancer, today announced that Robert
Kirkman, M.D., President and Chief Executive Officer, is scheduled to present
at two upcoming investment conferences.
